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To study trans-activation of gene expression by murine cytomegalovirus (MCMV) immediate-early (IE)
proteins, the IE coding region 1 (iel), which encodes the 89,000-Mr IE phosphoprotein (pp89), was stably
introduced into L cells. A cell line was selected and characterized that efficiently expressed the authentic viral
protein. The pp89 that was constitutively expressed in L cells stimulated the expression of transfected
recombinant constructs containing the bacterial chloramphenicol acetyltransferase (CAT) gene under the
control of viral promoters. The regulatory function of the iel product was confirmed by transient expression
assays in which MCMV IE genes were cotransfected into L cells together with recombinant constructs of the
CAT gene. For CAT activation by the iel product, a promoter region was required, but there was no
preferential activation of a herpes simplex virus type 1 delayed-early promoter. All plasmid constructs that
contained the intact coding sequences for pp89 induced gene expression in trans. The MCMV enhancer region
was not essential for the expression of a functional IE gene product, and testing of the cis-regulatory activity
of the MCMV enhancer revealed a low activity in L cells. Another region transcribed at IE times of infection,
IE coding region 2, was unable to induce CAT expression and also did not augment the functional activity of
iel after cotransfection.
Infection of the mouse with the murine cytomegalovirus
(MCMV) serves as a model to study a herpesvirus infection
in the natural host. The biological features of MCMV infec-
tion and human CMV (HCMV) infection are similar (13).
Both viruses have a genome of 235 kilobase pairs (kbp),
although the organization of the genomes is different (5, 26).
Similar to HCMV and other herpesviruses, MCMV genes
are expressed in three sequential phases which show coor-
dinated regulation and temporal control (14, 15, 17, 24). The
initial class of gene products, the immediate-early (IE)
polypeptides, is necessary for the next phase, in which the
early polypeptides are produced. Herpesviruses differ with
regard to the number of IE genes, and the function(s) of
individual IE gene products is unclear. Studies with temper-
ature-sensitive mutants revealed that in herpes simplex virus
type 1 (HSV-1) the protein Vmw-175 or ICP4 encoded by IE
gene 3 and in pseudorabies virus the single 180,000-Mr
(180K) IE gene product are continuously required for early
and late gene transcription (28, 31, 39). In HCMV three
regions of IE transcription have been defined (36), and a 72K
to 75K phosphoprotein may play a dominant role in the
regulation of HCMV gene expression (37). In MCMV the
major 89K IE phosphoprotein (pp89) is the candidate for a
regulatory protein (18).
Transfection assays with recombinant plasmids which
contain indicator genes linked to eucaryotic promoter- and
transcriptional-control elements provide the means to study
the effects of cis- and trans-activation of gene expression.
Imperiale et al. (16) and Green et al. (12) demonstrated that
after transfection of cells with plasmids containing the
pseudorabies virus IE gene, the pseudorabies virus IE gene
product activates in trans the expression of genes under
control of unrelated promoters. Everett (8) extended these
studies to IE genes of HSV-1, HCMV, and varizella-zoster
virus. Of the different HSV-1 IE genes the genes encoding
* Corresponding author.
the 175K, the 110K, and the 12K proteins appear to play a
direct or indirect role in trans-activation (8, 28). In addition,
Persson et al. (29) demonstrated that cells which constitu-
tively express HSV-1 IE genes can also activate other
herpesvirus genes in trans.
In this study, we set out to examine whether the gene
product of IE coding region 1 (iel), pp89, can act as an
activator of transcription. We transfected mouse L cells with
plasmids containing iel and selected clones that constitu-
tively express the iel gene product. We demonstrate that the
iel product can stimulate the expression of the chloramphen-
icol acetyltransferase (CAT) gene under control of eucary-
otic promoters, irrespective of whether pp89 is constitu-
tively or transiently expressed. In addition, the functional
activity of an IE coding region 2 (ie2) which gives rise to a
1.75-kb RNA was tested. The results suggest that only the
product of iel stimulates transcription.
MATERIALS AND METHODS
Virus and cell culture. MCMV (mouse salivary gland virus,
strain Smith, ATCC VR-194) was used and propagated in
BALB/c mouse embryo fibroblasts (MEF) as described
previously (5).
Ltk- clone 1D cells (19) were maintained in Dulbecco
modified Eagle medium containing 10% fetal calf serum
(Seromed, Munich, Federal Republic of Germany) supple-
mented with 100 U of penicillin and 100 ,ug of streptomycin
per ml. Cells were grown in plastic tissue culture dishes
(Greiner, Nurtingen, Federal Republic of Germany) or mi-
crotiter plates (Costar, Cambridge, Mass.). Cultures were
maintained at 37°C in 5% CO2.
Plasmids and cloning procedures. The cloning of MCMV
DNA fragments in the vectors pACYC177 and pACYC184
was done by established procedures (23) and has been
described before (5, 17). The physical map of the MCMV
genome and MCMV DNA fragments contained in plasmids
are shown in Fig. 1.
59
Vol. 58, No. 1
 at Universitaetsbibliothek M
uenchen on O
ctober 22, 2008 
jvi.asm.org
D
ow
nloaded from
 
60 KOSZINOWSKI ET AL.
I v I 9 I I I II I 1--l
0 map units 0.5 1
1 A 1 B M H PDC G F |KIL I JIIP E I
Hind m
ie 1 enhoncer ie 2
3.85kb 4.4kb j 2.45 kb j1.2 kb 2.75kb IO.kbI
0753 map units 0.769 0.787 0.798 0.803 0.815 0.818
pHind m K
pAMB 25
pMSV IE14
plE 111
plE 110
pHind m L
plE001
p IE 220
FIG. 1. Physical map of the MCMV genome. The location of the HindlIl cleavage sites is shown. The region encoding the 2.75-kb
transcript of iel and the 1.75-kb transcript of ie2 separated by the long >700-base-pair enhancer sequence is expanded. The plasmid
pMSV-IE14, which contains a 7.8-kb MCMV DNA fragment, was used for the introduction of iel into L cells. The 10.8-kb BamHI fragment
(plasmid pAMB25) was used as a probe to detect MCMV sequences inserted into cellular DNA and mRNA transcribed in L cells. The other
plasmids were used in transient assays to monitor the trans-activating function of the IE gene products. The arrows indicate the start and the
direction of transcription of the IE genes. Symbols: 0, HindIII; A, DraI; *, HpaI; 0, BamHI.
Plasmid pMSV (a gift from J. Doehmer) contains an EcoRI
fragment with the proviral genome of Moloney mouse sar-
coma virus (MSV), 100 base pairs of cellular sequences at
the 5' end of the provirus, and 2.1-kilobase-pair cellular
sequences at its 3' end (38). The plasmid pMSV-IE14 was
constructed by insertion of the 10.8-kb MCMV BamHI
fragment of plasmid pAMB25 (17) into the unique BglII site
of the MSV vector. The 10.8-kb MCMV BamHI fragment
contains the region encoding the major MCMV IE polypep-
tide (iel). In the plasmid pMSV-IE14 the gene encoding the
major IE polypeptide is transcribed in the direction opposite
to that of the retroviral genome. Sequences of 3 kb in size
were deleted at the 3' end of the IE gene during the cloning
procedure, probably due to the relaxation of the specificity
of the BamHI enzyme (9). After insertion of the MCMV
sequences the EcoRI fragment was 15.7 kb. The plasmids
pHindIII-K and pHindIII-L have been described previously
(5), and the other constructs (pIE111, pIEllO, pIE001,
pIE220) were subclones from pHindIII-K, pHindIII-L, or
pAMB25. The CAT plasmids pAlO-CAT2, pSV2-CAT, and
pSrM2-CAT (20) were obtained from P. Gruss; pSVO-CAT
(10) was from W. Doerfler; and pgD-CAT, which contains
the delayed early HSV-1 glycoprotein D promoter (6) in
front of the CAT gene, was from R. Everett. The CAT
plasmid pMCMV CAT was constructed by insertion of the
1.2-kb DraI-HpaI MCMV DNA fragment cloned in plasmid
pIE001 into the BglII site of pAlO-CAT2.
To provide a specific cRNA probe for the CAT gene, the
488-base-pair PvuII fragment of pSV2-CAT was cloned into
the SmaI site of pSP64 to obtain pSP-CAT.
DNA transfection. For transfection and selection of
transfectants, Ltk- cells (5 x 105 per dish) were seeded into
60-mm-diameter plastic plates 16 h prior to transfection. The
calcium phosphate precipitate technique (11) was used, and
1 ,ug of pAG60 DNA containing the kanamycin-neomycin
resistance gene (4) and 10 ,ug of plasmid DNA were added in
500-,ul precipitates per dish. Transfected cell cultures were
selected with the aminoglycoside G418 (250 ,ug/ml; Hoechst,
Frankfurt, Federal Republic of Germany). Cultures were
refed every 5 to 7 days. Colonies were counted 18 to 24 days
after transfection, and single colonies were picked using
cloning cylinders and analyzed for IE gene expression by
indirect immunofluorescence. Selected colonies were cloned
twice by limiting dilution.
For transient gene expression assays, cells were seeded
into 100-mm-diameter plates. The calcium phosphate precip-
itate technique or the DEAE-dextran method described by
Luthman and Magnusson (22) was applied. For transfection
of MEF only, the calcium phosphate precipitate technique
gave satisfactory results. Although by this technique the
highest conversion rates also were obtained with L cells, the
more reproducible DEAE-dextran precipitate technique was
applied in most of the experiments. This technique required
lower amounts of DNA than the calcium phosphate precip-
itate method (21) for efficient CAT gene expression. The
addition of carrier DNA to equalize the amount ofDNA used
for transfection had no effect on the resulting enzyme
activity. The experiments shown were carried out without
carrier DNA.
Analysis of DNA and RNA. Cells were harvested by
trypsinization and washed twice in Ca- and Mg-free phos-
phate-buffered saline. For the isolation of DNA, the cells
were suspended in 50 mM Tris hydrochloride (pH 7.5)-10
mM EDTA-2% sodium lauroyl sarcosinate (17). The cells
were treated with 200 ,ug of RNase A (Serva, Heidelberg,
Federal Republic of Germany) per ml for 60 min at 37°C and
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1 mg of proteinase K (Serva) per ml for 60 min at 56°C. The
DNA was extracted with phenol, chloroform-isoamyl alco-
hol (24:1), and ether. After ethanol precipitation the DNA
was suspended in 20 mM Tris hydrochloride (pH 8.0).
Purification of whole cell RNA, agarose gel electrophore-
sis of nucleic acids, and transfer on nitrocellulose was
carried out as described previously (5, 17, 18). Plasmids
were 32P-labeled by nick translation and hybridized to the
immobilized RNA or DNA. Northern and Southern blots
were exposed to Kodak X-Omat AR films.
Whole cell DNA from transfected cells was harvested
from double plates at various times after transfection. DNA
(10 pLg) was blotted onto nitrocellulose with a slot blot device
(Schleicher & Schuell, Dassel, Federal Republic of Ger-
many). Plasmid DNA was visualized by hybridization with a
specific cRNA hybridization probe synthesized from pSP-
CAT, a plasmid containing the bacteriophage SP6 promoter
(25). For the preparation of cRNA the plasmid was linear-
ized by cleavage with PstI, and cRNA was transcribed in the
presence of 50 ,uCi of [32P]UTP (800 Ci/mmol; Amersham
Corp., Arlington Heights, Ill.) as described by Melton et al.
(25).
Radioimmunoprecipitation. [35S]methionine labeling of
cells, preparation of cell lysates, and immunoprecipitation
with monoclonal antibody were carried out as described
previously (18).
Assay of CAT activity. Cells were harvested by using a
rubber policeman 40 h after transfection, and cell extracts
were prepared after sonication by the procedure of Gorman
et al. (10). The standard assay mixture contained (in a final
volume of 180 ,u1 of 0.25 M Tris hydrochloride [pH 7.5]) 20 ,ul
of cell extract, 20 ,ul of 4 mM acetyl coenzyme A, and 1.5 ,u1
of [14C]chloramphenicol (0.2 ,uCi/ml; Amersham). The mix-
ture was incubated at 37°C for 60 to 120 min, and the
chloramphenicol was extracted and run on thin-layer chro-
matography plates. Radioactive chloramphenicol was visu-
alized after overnight exposure to Kodak X-Omat S films.
After autoradiography the acetylated chloramphenicol forms
were excised and counted in a liquid scintillation counter.
Under the conditions described, the assay was linear with
respect to time and concentration of standard enzyme until a
conversion rate of about 70% acetylated products was ob-
tained. At least two replicate determinations for each trans-
fection protocol were carried out in each individual experi-
ment and were found to differ by not more than 2%.
However, some differences were seen between results of
individual experiments.
RESULTS
Transient and constitutive expression of the product of iel.
The MCMV region of abundant IE RNA transcription spans
from map unit 0.769 to 0.817 and codes for one major IE
RNA size class of 2.75 kb and several less-abundant RNA
species (17). The 2.75-kb mRNA is translated into pp89
which is cleaved in vivo by host cell proteases into a 76K
derivate (pp76). Both proteins are transported to the nucleus
(18). In analogy to the major IE gene of HCMV (37), we
denote the region encoding pp89, which is contained is
plasmids pAMB25, pIEll, pIE110, and pMSV-IE14, as iel.
iel and ie2, which is entirely located within HindIII-L (5),
are separated by a long enhancer sequence (K. Dorsch-
Hasler, G. Keil, F. Weber, M. Jasin, W. Schaffner, and U.
H. Koszinowski, Proc. Natl. Acad. Sci. USA, in press).
For the introduction of iel into cellular DNA, Ltk- cells
were cotransfected with pMSV-IE14 and pAG60 (4). Colo-
nies which exhibited antigen-specific fluorescence in the
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FIG. 2. Characterization of cells expressing pp89. (a, top) Indi-
rect immunofluorescence showing nuclear expression of MCMV IE
antigen in the transfected cell line 45/1. (a, bottom) Corresponding
phase-contrast microscopic view of cell line 45/1. (b) Sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (10% gels) of
35S-labeled proteins immunoprecipitated from cell lysates by mono-
clonal antibody MCMV to pp89. Cell lysates were from MEF
infected (multiplicity of infection, 10) with MCMV in the presence of
cycloheximide and labeled after exchange of cycloheximide for
actinomycin D 3 h later (lane 1); Ltk- cells (lane 2); and 45/1 cells
(lane 3). (c) Northern blot analysis ofRNA from MEF infected with
MCMV in the presence of cycloheximide (lane 1); Ltk- cells (lane
2); and 45/1 cells (lane 3). A 0.5-,ug portion of infected MEF RNA
and 5-,ug portions of RNA from Ltk- cells and 45/1 cells were
fractionated on 1% agarose-formaldehyde gels, transferred to nitro-
cellulose paper, and hybridized to the 32P-labeled BamHI fragment
of plasmid pAMB25. (d) Southern blot analysis of MCMV DNA
introduced into L cells. To detect inserted sequences, the BamHI
insert of pAMB25 probe was used. Lane 1, 0.5 ng DNA of plasmid
pMSV-IE14 added to 10 ,ug of Ltk- DNA and cleaved with EcoRI;
lane 2, 10 ,ug of DNA of 45/1 cells after digestion with EcoRI. Both
samples were run on the same gel. kbp, Kilobase pairs.
majority of nuclei (Fig. 2a) were cloned. Because dividing
cells gave a bright signal while cells grown to confluence
gave almost no signal, the expression of the antigen ap-
peared to be cell cycle dependent. For characterization of
the antigen, viral polypeptides synthesized in clone 45/1
were compared with products from infected MEF (Fig. 2b).
In lysates of infected MEF (Fig. 2b, lane 1) and cell line 45/1
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FIG. 3. CAT activation by the constitutively expressed product
of iel. Monolayers of Ltk- cells 45/1 cells were transfected by the
calcium phosphate precipitate technique with 25 ,ug of DNA of
plasmid pA10-CAT2 or with 25 ,ug of DNA of plasmid pSrM2-CAT.
Cells were harvested 40 h later, and 20-,ul protein extracts were
assayed for CAT activity. The chromatogram of CAT assays is
shown. All samples were run on the same thin-layer plate, although
at different positions. The first lane (CAT-Enzyme) shows the
conversion products obtained with 0.6 U of a commercial CAT
preparation.
(Fig. 2b, lane 3), pp89 and pp76 were detected after immu-
noprecipitation and were absent in the nontransfected L
cells (Fig. 2, lane 2).
The viral RNA synthesized in 45/1 cells was analyzed by
Northern blotting and compared with the RNA transcribed
at IE times in infected MEF (Fig. 2c). Using the nick-
translated BamHI insert of pAMB25 as probe, a 2.75-kb
RNA expressed in infected cells (Fig. 2c, lane 1) (17) was
also detected in RNA from 45/1 cells (Fig. 2c, lane 3). In
RNA from L cells no hybridization was seen (Fig. 2c, lane
2).
To examine the integration of MCMV sequences into
cellular DNA, 45/1 DNA was analyzed by restriction en-
zyme digestion followed by agarose gel electrophoresis and
Southern blotting. Figure 2d shows the results obtained after
cleavage with EcoRI, which cuts pMSV-IE14 on both sides
of the MSV vector-plasmid junctions. By using the nick-
translated internal BamHI fragment of pAMB25 as probe,
strong hybridization to the 15.7-kb EcoRI fragment of
pMSV-IE14 was seen. The analysis of 45/1 DNA revealed
eight discrete bands that hybridized to MCMV DNA. The
different size of the hybridizing bands indicated several
inserts. Dot blot analysis revealed the presence of about 10
equivalents of the region transferred by pMSV-IE14 (data
not shown).
45/1 cells therefore contain at least one active copy of iel
from which a RNA of the correct size is transcribed. This
RNA is translated into a protein that is indistinguishable
C4 from the viral pp89.
Induction of CAT gene expression in 45/1 cells. To deter-
o mine whether the viral IE protein constitutively expressed in
O L cells could stimulate expression of the CAT gene under
control of a eucaryotic promoter, L cells and 45/1 cells were
transfected with DNA of pSRM2-CAT, which contains the
MSV enhancer upstream of the simian virus 40 (SV40)
promoter (22), or with pAlO-CAT2, which contains the
enhancerless SV40 promoter (20). The enzyme level ex-
pressed from the CAT gene in transient assays correlates
with the level of mRNA and thus provides a test to estimate
promoter activity (10). The expression of pSrM2-CAT was
similar in L cells and 45/1 cells (Fig. 3). However, transfec-
tion of pA10-CAT2 into 45/1 cells resulted in high levels of
CAT activity, whereas with transfection into L cells no
enzyme activity could be detected. Results comparable with
those obtained with 45/1 cells were obtained also with five
other L-cell clones that were stably transfected with iel
(data not shown).
45/1 cells are a subclone of the L-cell line; still, both lines
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FIG. 4. Stability of transfected plasmid DNA in L cells and 45/1
cells which express pp89 of MCMV. Cells were transfected with 10
,ug of pSrM2-CAT, and whole cell DNA was extracted at various
times. The time point after removal of the calcium phosphate
precipitate was taken as the sample at 0 h. Two replicate plates were
extracted. Total DNA (10 ,ug) was blotted onto nitrocellulose and
hybridized to a [32P]cRNA probe specific for the CAT gene. The
amount of plasmid DNA in cells was determined by autoradiography
using a standard dilution of plasmid DNA. The results were cor-
rected for the number of cells per culture dish determined at 0 h to
exclude the effect of different growth rates. Four replicate determi-
nations were carried out at 40 h; two were used for the determina-
tion of CAT activity. The chloramphenicol conversion rate by
extracts from L cells was 46% and from 45/1 cells was 45%.
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FIG. 5. CAT expression after cotransfection of MCMV sequences. (a) Requirement of promoter sequences in the CAT construct. DNA
(10 ,ug) of plasmids containing the CAT gene constructs with (pAlO-CAT2) or without (pSVO-CAT) the SV40 promoter region were
transfected by the DEAE-dextran precipitate technique into L cells in the presence or absence of 2 p.g ofDNA of plasmid pAMB25 containing
iel. Extracts were prepared and assayed for CAT activity 40 h later. (b) MCMV genes and sequences required for CAT induction. DNA (10
,ug) of plasmid pAlO-CAT2 was transfected together with 2 ,ug of DNA of plasmids containing sequences of the MCMV IE region (Fig. 1).
pAMB25 contained the complete iel sequences and the ie2 lacking the 3' end of the gene. HindIII cleaved inside and BamHI cleaved outside
the iel protein coding sequences. pHindIII-K lacked the 5' end of the gene in iel. pHindIII-L contained the complete ie2 sequences, and
pIE220 contained ie2 without the enhancer sequences and the 3' end of the ie2 gene. pIElll and pIE110 contained the complete iel protein
coding sequences, but pIE110 lacked the enhancer sequences. pIE001 contained the enhancer sequences but not the transcription start sites
in iel and ie2. A control for transfection efficiency (pSrM2-CAT) was included. Cell extracts were prepared 40 h after DEAE-dextran
precipitate transfection and assayed for CAT activity.
could be differentially susceptible to transfection proce-
dures. The percentage of transfected cells can vary in
different cell lines, and the amount of plasmid DNA main-
tained by a transfected cell can also be variable and lead to
different levels of gene expression. A control therefore was
needed to compare the transfection conditions of L cells and
the 45/1 derivative. The amount of transfected plasmid DNA
present in cells at various times after transfection was
determined and used as a standardization parameter (1). The
stability of pSrM2-CAT DNA during the 70 h following
transfection was analyzed (Fig. 4). Within the first 20 h about
94% of the transfected DNA was lost. At 40 h after trans-
fection the level of CAT expression was tested. There was
no difference between the two cell lines with regard to
uptake of plasmid DNA, plasmid DNA stability, and CAT
expression. Thus, the presence of pp89 in L cells stimulated
the expression of a transfected gene in trans.
Activation of CAT after transient expression of iel. The
conclusion that pp89 activates transcription was confirmed
and extended by transient expression assays. After cotrans-
fection of L cells with iel, which is contained in pAMB25,
and pAlO-CAT2, followed by incubation for 40 h, the
amount of synthesized CAT activity was assayed. The
results (Fig. 5) reveal the trans-activating function of the iel
product also under these conditions. To test whether CAT
gene expression requires the presence of transcriptional
control elements for trans-activation, the enzymatic activity
after cotransfection of iel and pSVO-CAT (10), which lacks
the promoter-regulator region, was tested. The absence of
detectable CAT activity with pSVO-CAT indicated that
promoter elements are essential for gene expression stimu-
lated by the MCMV IE gene product (Fig. Sa).
In a study on transient gene activation by HSV-1 IE genes,
O'Hare and Hayward (28) observed a requirement for ho-
mologous promoters. While the SV40 promoter in pA10-
CAT2 could only weakly be activated by HSV-1 IE gene
products and had to be replaced by HSV-1 delayed-early
promoters (28), the presence of pp89 resulted in up to a
50-fold induction of CAT activity with plasmid pA10-CAT2
(see above). The specificity for homologous promoters could
not be tested in our study because no early MCMV promoter
has been characterized so far. To test the induction of CAT
activity with the CAT gene under control of at least a
herpesvirus promoter, we tested plasmid pgD-CAT, which
contains the delayed early HSV-1 gD promoter (6; data not
shown). Different to the results obtained with pA10-CAT2,
the transfection of pgD-CAT alone resulted in an increased
basal level of enzyme activity. The finding that the stimula-
tion due to iel cotransfection was usually about threefold led
us to conclude that induction of transcription by the iel
product does not preferentially act on a herpesvirus pro-
moter.
No trans-activation by ie2. In HSV-1 more than one IE
gene product can act as activator of transcription, and the
combination of certain IE genes provides a higher level of
activation than a single IE gene (5, 16). Therefore, plasmid
pHindIII-L, which contains ie2, was tested either alone or in
combination with iel. The results show clearly (Fig. Sb) that
the transfection of ie2 sequences alone does not stimulate
gene expression. After cotransfection of iel (pIElll) and ie2
(pHindIII-L), there was no augmented activity of pp89. In
fact, in the majority of experiments the effect of the iel
product was even lower after cotransfection of both iel and
ie2.
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To study whether induction of gene expression requires
intact IE genes, constructs containing fragments of iel
(pHindIII-K) or ie2 (pIE220) were tested and found to be
ineffective. Furthermore, pAMB25 was cleaved with
Hindlll, which cuts within iel, and with BamHI, which cuts
outside of iel (Fig. 5b; see also Fig. 1). The linearization did
not affect the function of iel, whereas HindIII cleavage
within the protein-coding region abolished trans-activation.
Therefore, trans-activation requires the intact coding region
of pp89. In the constructs pAMB25 and pIE111, the se-
quences encoding pp89 are under control of the MCMV
enhancer. The enhancer also controls ie2 in the construct
pHindIII-L. The proposition that the induction seen in the
transient expression assays is due to a recombination event
(30), resulting in the introduction of the MCMV enhancer
sequences in a position leading to activation of the CAT gene
in cis, is unlikely, because cotransfection of the isolated
enhancer region cloned in plasmid pIE001 showed no effect
(Fig. 5).
Expression of iel in the absence of the MCMV enhancer and
low activity of MCMV enhancer sequences in L cells. At-
tempts to demonstrate trans-activation of MCMV early
genes after superinfection of 45/1 cells failed, and the anal-
ysis of MCMV transcriptional activity in L cells revealed
that pp89 is not expressed after infection (data not shown).
We reasoned that in L cells the MCMV enhancer has a low
activity. To test the enhancer requirement for iel gene
function, the enhancer element was deleted from plasmid
pIE111 to give plasmid pIE110. Results (Fig. Sb) show that
the enhancer is not essential for iel function.
Because these results suggest that there is a strong iel
promoter but do not prove the low activity of the MCMV
enhancer in L cells, the enhancer sequences were inserted
upstream of the SV40 promoter in pA10-CAT2 to give
pMCMV-CAT. The cis-acting activity of the MCMV en-
hancer sequences on CAT expression was studied in L cells
and MEF, in which MCMV can replicate. For comparison
the cells were transfected also with pSrM2-CAT and pA10-
CAT2. The results (Fig. 6) show that the activity of the
MCMV enhancer in L cells is lower than that of the MSV
enhancer. However, when tested in MEF the activation by
the MCMV enhancer was higher. This observation was
independent of the transfection protocol used (data not
shown).
Although activation of CAT gene expression in L cells by
pMCMV-CAT was low, the IE gene was expressed in L cells
after transfection of pIE110, and the inability to demonstrate
IE gene expression after infection remained unexplained.
MEF and L cells were therefore infected with 5 to 500 PFU
of MCMV in the presence of actinomycin D to prevent
transcription (33). After infection with 5 PFU, about 80% of
nuclei of infected MEF were positive by in situ hybridiza-
tion, while the nuclei of L cells showed grain numbers in the
range of the uninfected control cells, even after infection
with 500 PFU of MCMV, which indicates the resistance of
this cell line to infection (K. Munch, unpublished data).
DISCUSSION
In this report we have described experiments designed to
study the effect of MCMV IE genes on the expression of
unrelated genes to identify viral IE genes that are active in
transcriptional regulation. We demonstrated that the product
of iel, pp89, can act as an activator of gene expression,
independent of whether the gene is constitutively or tran-
siently expressed after transfection. Another IE gene, which
is located in ie2 but which is less abundantly transcribed at
IE times, could not induce gene expression and failed to
augment the function of the product of iel.
By preparing cell lines that constitutively express a viral
IE gene and by testing IE gene constructs in transient assay
systems, we intended to combine the advantages of both
techniques and to avoid their inherent shortcomings. One
advantage of transformed cell lines is the expression of the
test gene in the majority of cells and the low probability of
recombination events during the transient expression of the
indicator gene (30). Cell lines offer the possibility to test, by
superinfection, whether herpesvirus early genes can be
expressed in the absence of de novo viral protein synthesis
(29). Unfortunately, in established cell lines only a limited
range of gene constructs can be tested during a given period
of time, and proof that the demonstrated effects are solely
due to the expression of the regulatory gene is difficult to
obtain. However, for the 45/1 cells we showed that the
results are not due to artifacts such as different levels of
plasmid DNA uptake and maintenance which can lead to
CAT expression because of the cumulative effect of the basal
promoter activity (1). Furthermore, there was no indication
for the repression of enhancer-induced stimulation of tran-
scription by pp89, as has been shown for 293 cells which
express the adenovirus Ela and Elb products (2).
The main advantage of transient assays is the quick
information about certain functional aspects of complete
viral genes or viral control elements. The identical results
obtained by using both techniques revealed that pp89 acts as
transcriptional activator, and putative effects of cis-acting
enhancer sequences due to recombination events (30) can be
excluded.
Although certain transfected herpesvirus IE genes can
trans-activate the expression of genes under control of
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FIG. 6. Cell-specific activity of the MCMV enhancer. DNA of
plasmids containing the CAT gene construct and the SV40 promoter
alone (pAlO-CAT2) or, in addition, the MSV long terminal repeat
enhancer (pSrM2-CAT) or the MCMV enhancer sequences
(pMCMV-CAT) were transfected into MEF (a) or L cells (b). For
transfection of MEF, 20 jig of calcium phosphate-precipitated DNA
was used, and Ltk- cells were transfected with 5 ,ug ofDNA by the
DEAE-dextran precipitate technique. Cell extracts were prepared
40 h later and assayed for CAT activity.
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unrelated promoters (7, 8, 12, 16), there may be differences
with regard to the degree to activation. O'Hare and Hayward
(27, 28) have reported that homologous HSV-1 promoters
are required for efficient CAT gene expression after trans-
fection of HSV-1 IE genes. Everett (7) observed low tran-
scriptional activation of the unrelated HSV-1 gD promoter
after cotransfection with the HCMV IE gene. We have
shown here that pp89 can activate both the SV40 and the
HSV-1 gD promoter and that there is no preferential activa-
tion of the herpesvirus promoter. The identification of a
homologous MCMV promoter to be tested in these assays is
under way.
Single IE gene products of pseudorabies virus and
varizella-zoster virus are efficient trans-activators (8, 12, 16).
A different situation is found in HSV-1. In HeLa cells
Vmw-175 (ICP4) alone was found to act as an activator of
transcription, and the combination of Vmw-175 and
Vmw-110 (ICPO) led to an increase of indicator gene expres-
sion (8). In Vero cells, Vmw-110 alone had also trans-
activating activity, and the 12K IE protein augmented the
stimulatory activity of Vmw-175 and Vmw-110 (28). It thus
appears that the cell lines used for transient expression
assays may influence trans-activator function and promoter
specificity. Although we demonstrated transcriptional regu-
lation by pp89 after constitutive and transient expression in
L cells, the L cells and 45/1 cells were refractory to MCMV
gene expression and replication after infection. This is
probably due mainly to the failure of virion uptake or DNA
transport to the nucleus or both.
There was no indication that the product of ie2 can
stimulate transcription or support the activity of iel. Be-
cause we could not demonstrate activation of MCMV early
genes in 45/1 cells by superinfection, we currently cannot
exclude the possibility of a role of ie2 in the activation of
homologous early promoters. The testing of cells that are
permissive for MCMV infection and susceptible to efficient
transfection experiments should help to clarify the role of
ie2. We are now in the process of screening various murine
cell lines.
From their study on the activation of gene expression by
adenovirus and herpesvirus regulatory genes, Imperiale et
al. (16) predicted that there are enhancer elements in the
region of herpesvirus IE genes. A strong enhancer has been
detected in the IE region of HCMV (3). Similar to HCMV, a
very long enhancer sequence is present also in MCMV
which separates iel and ie2. The MCMV enhancer is, apart
from the HCMV enhancer, the strongest one found to date,
and in addition the MCMV enhancer has a wide host cell
range (K. Dorsch-Hasler et al., in press). The first event of
CMV replication, the constitutive transcription of IE genes,
is suggested to be under the control of the IE enhancer (3)
which directs gene expression in cis. It was therefore sur-
prising that in L cells the enhancer had a low activity,
whereas the expression of the IE protein did not require the
presence of the enhancer sequence. This indicates a tissue-
specific function of the MCMV enhancer and suggests that
the IE gene encoding pp89 contains an effective promoter.
Cell lines that constitutively express IE gene products
may serve to help study other aspects of CMV infection.
MCMV IE antigens are recognized by cytolytic T-
lymphocyte populations (33, 34) and by IE antigen-specific
cytolytic T-lymphocyte clones (32). Because cytolytic T
lymphocytes are involved in the control of the spread of
MCMV infection, IE antigen expression can be implicated in
immune surveillance (35). IE gene products expressed in
transfectants in association with the appropriate class I gene
products of the major histocompatibility complex will help to
define the molecular properties of the antigen(s) recognized
by effector T cells.
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